PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. - Wikidata - awgldk - TriplyDB

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

http://www.wikidata.org/entity/Q34726807

about

CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Diagnosis of hepatocellular carcinoma.Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1 The association of HMGB1 gene with the prognosis of HCC.The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes.AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion.Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif.Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.The 4th Asia-Pacific Primary Liver Cancer Expert Meeting Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.An isolated metachronous metastasis to the adrenal gland from a pancreatic neuroendocrine tumor: A case report.Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong

P2860

Q26999045-021FC710-ED86-42CF-A39D-E0DC71A6C29D Q28392783-B430E677-2C7B-4CF1-87B6-035F91784D7C Q28394414-6C4EA098-4247-47AE-9C94-54D14D75112D Q30490554-DC873730-DEF9-408C-8C26-288A332403EA Q33775228-5B279AAE-5C57-4744-9646-6314779D79C6 Q34647652-A66D322C-D8D0-456A-BA8F-A428FD1E279E Q35080145-48FC1691-0903-4D32-99A1-031B1AB19A03 Q35097379-8302064B-176F-46C0-B70A-C9733335A8EF Q35106665-151EF725-EBCB-4F0F-B6D6-9DBAE67116CF Q35177271-9695EE4D-71BB-4A13-B850-15935B78E85D Q35753801-0E1C35AC-A5D0-464B-AAD6-F8A173E860CE Q35987232-93F9CCFC-9CCD-463E-8CD4-55D98762136E Q36082480-DBA7295C-2284-4158-8BAB-F9DBB8A60FF0 Q37404644-20E04283-9272-403F-8DCC-0BF93EE40358 Q37425226-E32406B9-3B2F-4F6B-8900-2A5F2D2A6C2F Q37568646-ACBD638F-D553-4CA4-BED0-4443F69E015B Q37578500-678F18C9-7DE6-41C5-BBBD-0F619760DDD4 Q37687816-F1976CB9-A6ED-41A0-BAF0-02106A87FB9F Q37972806-5B937130-1C0C-4386-B677-9DE92BDA2379 Q38120063-480B2890-C2EC-4F3B-8350-7FA73CA11DF2 Q38374068-BDF460B4-B8CB-45CA-9C86-6ECBE5936300 Q38692450-CD8316C5-47ED-4F58-8891-C093E258E642 Q38849845-0BB33888-4C0E-428C-8530-D1F06D6001C7 Q39556002-437B1B13-0FB2-409A-8FD5-1E605FBF82C2 Q40572955-4893F948-18CD-4E17-80F1-7B7D1ED00AA2 Q42270431-4532A73C-2BC8-4AC2-B605-FF898B8DA8A0 Q43183158-29795BFF-48A1-4BBD-B3DE-DFA456B7F492 Q43714851-3B9D5F5A-6AC3-460C-8E0F-276870806FE4 Q47121517-12E8FFE0-BFF7-43B6-9AFD-E8EB5F40D502 Q47911866-E1281206-414F-44B6-9CE3-4251CB697DC9 Q49197751-1983175D-37AD-444D-9F58-4B3628958D0F Q57066918-185BD983-AEED-47A8-8E30-2136EEBDA316

P2860

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

http://www.wikidata.org/entity/Q34726807

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@ast

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@en

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@nl

type

label

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@ast

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@en

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@nl

prefLabel

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@ast

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@en

PIVKA-II is a useful tumor mar ...... noma after surgical resection.

@nl

P1433

Q34726807-D99787D3-584A-4641-9378-FC1D35880281

P1476

Q34726807-92AC61B2-2665-4FEE-B46D-2EC710B46CCE

P2093

Q34726807-7D7E7F11-F04F-4D51-A7AD-0216245E7A24

Q34726807-7EBE0B9E-C1C6-4203-9EFB-3060700B121C

Q34726807-8F17FDF9-028A-44E4-98D8-F65BD51FA5FC

Q34726807-CCF3C60A-1D40-4EC6-A6EB-1C9D5EFB8D06

Q34726807-D970588F-67DB-46E6-86CF-856BFD800A59

Q34726807-E21C5B38-AC5A-433C-9C21-A390AC124BAF

P2860

Q34726807-1D3485E4-5DEB-479D-8CD7-3DD978A14A6E

Q34726807-5144DFD2-598C-407B-9734-46618966FD79

Q34726807-C7BAEF7A-700D-4A73-85BB-DD25367996C2

P304

Q34726807-62B3F699-A861-4864-A01C-2120BBAA73B3

P31

Q34726807-AA121839-09EB-40E5-8CF1-2CDBEF4F9795

P356

Q34726807-44321FBE-78BE-4DD0-A8FE-D859935AEBDD

P478

Q34726807-05930684-213B-4BE5-AC4F-CACD794DB6C3

P50

Q34726807-03BFE2A5-0050-444C-9BD6-40DD09D7ADA1

Q34726807-0E80B9CA-CD87-42FA-AED8-E8585B95A973

Q34726807-7C1D28AE-912F-4B42-A699-FBE243152E5B

P577

Q34726807-57334958-A807-4A11-9AB2-6C968B05D3C5

P698

Q34726807-21D4D990-3303-4961-A265-8B10127BCAD1

P356

P1433

P1476

PIVKA-II is a useful tumor mar ...... inoma after surgical resection

@en

P2093

Chae Yoon Chon

http://www.w3.org/2001/XMLSchema#string

Do Young Kim

http://www.w3.org/2001/XMLSchema#string

Ja Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Jong Won Choi

http://www.w3.org/2001/XMLSchema#string

Yong Han Paik

http://www.w3.org/2001/XMLSchema#string

Young Jun Youn

http://www.w3.org/2001/XMLSchema#string

P2860

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Resection and liver transplantation for hepatocellular carcinoma.

Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

P304

52-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000111707

http://www.w3.org/2001/XMLSchema#string

P478

72 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18087182

http://www.w3.org/2001/XMLSchema#string